With this approach, Avci hopes that the COMB-O will be the first ultra-sensitive, low-cost and easy-to-use PoC (point-of-care) optical biomarker detection platform that can be developed as a disposable screening or diagnostic test. For lung cancer, the first target, this would be the first PoC detection method. Read more
Dr. Imran Avci receives Open Technology Programme AES funding
24 June 2021
Implementing light sources, detectors and sensing elements on a single optical chip for better results in routine cancer diagnosis and screening. Imran Avci of the Vrije Universiteit Amsterdam has received a grant from the Open Technology Program AES (NWO) to develop this optical chip, the COMB-O.